Purity Specifications, Storage and Distribution for Medications Development
Closed Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest special notice from .
- Solicitation number
- N01DA-22-8961
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks offers to provide purity specifications, storage, and distribution services for medication development to the National Institute on Drug Abuse and other NIH institutes. Offerors must propose to serve as a centralized repository to receive, analyze, and store compounds from domestic and foreign submitters for evaluation as potential treatment agents, standards, and screening agents. The base period of performance is July 2022 through July 2023, with four optional one-year extensions. Proposals must be submitted by February 11, 2022 and will be evaluated based on technical qualifications, past performance, and pricing.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R425. The selected offeror must comply with DEA registration requirements, handle toxic substances, and the place of performance will be the offeror's facility. Key details include the solicitation includes pricing terms for the base period and optional quantities, some compounds may be neurotoxins, and the selected contractor must have the capability to receive, analyze, and store compounds within required timeframes and purity specifications.
Notice text
Please see the attached RFP package.
Files
| File | Type | Posted |
|---|---|---|
| RFP package.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Purity Specifications, Storage and Distribution for Medications Development | Award Notice | |
| Purity Specifications, Storage and Distribution for Medications Development | Special Notice | |
| This notice | Solicitation | |
| Purity Specifications, Storage and Distribution for Medications Development | Pre-Solicitation | |
| Purity Specifications, Storage and Distribution for Medications Development | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - B2B Award entitled - Developing Red Cell-Sp | Office of Logisitics and Acquisition Operations | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Tau radiotracers for Baltimore Longitudinal Study of Aging | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity